Special Reports
The Lower Middle Market M&A Landscape for Professional Services:
H1 2026 Report
See what buyers paid for professional services firms in H1 2026 and what separated premium exits from discounted ones:
-
Valuation Benchmarks: EBITDA multiples across IT services, accounting, wealth management, consulting, and agencies.
-
Premium and Discount Triggers: What buyers reward and the risks that cost sellers full turns of EBITDA.
-
Deal Structures: How earnouts, rollover equity, and QoE requirements shape what sellers actually keep.
-
The 36-Month Playbook: The preparation sequence worth 0.5x to 1.5x in additional multiple.
Download the full report to see where your firm stands before a buyer tells you.
Get an executive-level analysis of the key trends from the 2025 JP Morgan Healthcare Conference that will shape the biopharma and medtech landscape. This comprehensive briefing covers:
-
M&A activity and the $1.3 trillion in "firepower" held by top 25 biopharma companies
-
Breakthrough developments in GLP-1 therapeutics, oncology, RNA therapeutics, and gene editing
-
AI and digital health transformation driving $25B+ in funding
-
Venture capital trends and investment priorities
-
Strategic implications of the new Trump administration
Based on insights from 8,000 industry leaders and 500 company presentations, this report provides actionable recommendations for healthcare executives to capitalize on the evolving market dynamics.
